BioRender 아이콘

Lymphoblast 2

Lymphoblast 2 - Editable icon of A circular cell with a large circular nucleus that takes up most of the space within the cell.
[{"image":"https://icons.cdn.biorender.com/w75xh75/605a139bc749650026702eab/605a131fc749650026702e79.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a139bc749650026702eab/605a131fc749650026702e79.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a139bc749650026702eaa/605a131fc749650026702e79.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a139bc749650026702eaa/605a131fc749650026702e79.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a139bc749650026702ea9/605a131fc749650026702e79.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a139bc749650026702ea9/605a131fc749650026702e79.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a139bc749650026702ea8/605a131fc749650026702e79.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a139bc749650026702ea8/605a131fc749650026702e79.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a139bc749650026702ea7/605a131fc749650026702e79.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a139bc749650026702ea7/605a131fc749650026702e79.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a139bc749650026702ea6/605a131fc749650026702e79.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a139bc749650026702ea6/605a131fc749650026702e79.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a139bc749650026702ea5/605a131fc749650026702e79.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a139bc749650026702ea5/605a131fc749650026702e79.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a139bc749650026702ea4/605a131fc749650026702e79.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a139bc749650026702ea4/605a131fc749650026702e79.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a139bc749650026702ea3/605a131fc749650026702e79.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a139bc749650026702ea3/605a131fc749650026702e79.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a139bc749650026702ea2/605a131fc749650026702e79.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a139bc749650026702ea2/605a131fc749650026702e79.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a139bc749650026702ea1/605a131fc749650026702e79.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a139bc749650026702ea1/605a131fc749650026702e79.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a139bc749650026702ea0/605a131fc749650026702e79.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a139bc749650026702ea0/605a131fc749650026702e79.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a139bc749650026702e9f/605a131fc749650026702e79.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a139bc749650026702e9f/605a131fc749650026702e79.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a139bc749650026702e9e/605a131fc749650026702e79.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a139bc749650026702e9e/605a131fc749650026702e79.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a139bc749650026702e9d/605a131fc749650026702e79.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a139bc749650026702e9d/605a131fc749650026702e79.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a139bc749650026702e9c/605a131fc749650026702e79.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a139bc749650026702e9c/605a131fc749650026702e79.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a139bc749650026702e9b/605a131fc749650026702e79.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a139bc749650026702e9b/605a131fc749650026702e79.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a139bc749650026702e9a/605a131fc749650026702e79.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a139bc749650026702e9a/605a131fc749650026702e79.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a139bc749650026702e99/605a131fc749650026702e79.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a139bc749650026702e99/605a131fc749650026702e79.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a139bc749650026702e98/605a131fc749650026702e79.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a139bc749650026702e98/605a131fc749650026702e79.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a139bc749650026702e97/605a131fc749650026702e79.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a139bc749650026702e97/605a131fc749650026702e79.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a139bc749650026702e96/605a131fc749650026702e79.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a139bc749650026702e96/605a131fc749650026702e79.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a139bc749650026702e95/605a131fc749650026702e79.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a139bc749650026702e95/605a131fc749650026702e79.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a139bc749650026702e94/605a131fc749650026702e79.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a139bc749650026702e94/605a131fc749650026702e79.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a139bc749650026702e93/605a131fc749650026702e79.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a139bc749650026702e93/605a131fc749650026702e79.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a139bc749650026702e92/605a131fc749650026702e79.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a139bc749650026702e92/605a131fc749650026702e79.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a139bc749650026702e91/605a131fc749650026702e79.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a139bc749650026702e91/605a131fc749650026702e79.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a139bc749650026702e90/605a131fc749650026702e79.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a139bc749650026702e90/605a131fc749650026702e79.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a139bc749650026702e8f/605a131fc749650026702e79.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a139bc749650026702e8f/605a131fc749650026702e79.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a139bc749650026702e8e/605a131fc749650026702e79.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a139bc749650026702e8e/605a131fc749650026702e79.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a139bc749650026702e8d/605a131fc749650026702e79.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a139bc749650026702e8d/605a131fc749650026702e79.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a139bc749650026702e8c/605a131fc749650026702e79.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a139bc749650026702e8c/605a131fc749650026702e79.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a139bc749650026702e8b/605a131fc749650026702e79.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a139bc749650026702e8b/605a131fc749650026702e79.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a139bc749650026702e8a/605a131fc749650026702e79.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a139bc749650026702e8a/605a131fc749650026702e79.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a139bc749650026702e89/605a131fc749650026702e79.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a139bc749650026702e89/605a131fc749650026702e79.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a139bc749650026702e88/605a131fc749650026702e79.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a139bc749650026702e88/605a131fc749650026702e79.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a139bc749650026702e87/605a131fc749650026702e79.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a139bc749650026702e87/605a131fc749650026702e79.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a139bc749650026702e86/605a131fc749650026702e79.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a139bc749650026702e86/605a131fc749650026702e79.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a139bc749650026702e85/605a131fc749650026702e79.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a139bc749650026702e85/605a131fc749650026702e79.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a139bc749650026702e84/605a131fc749650026702e79.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a139bc749650026702e84/605a131fc749650026702e79.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a139bc749650026702e83/605a131fc749650026702e79.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a139bc749650026702e83/605a131fc749650026702e79.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a139bc749650026702e82/605a131fc749650026702e79.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a139bc749650026702e82/605a131fc749650026702e79.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a139bc749650026702e81/605a131fc749650026702e79.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a139bc749650026702e81/605a131fc749650026702e79.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a139bc749650026702e80/605a131fc749650026702e79.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a139bc749650026702e80/605a131fc749650026702e79.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a139bc749650026702e7f/605a131fc749650026702e79.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a139bc749650026702e7f/605a131fc749650026702e79.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a139bc749650026702e7e/605a131fc749650026702e79.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a139bc749650026702e7e/605a131fc749650026702e79.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a139bc749650026702e7d/605a131fc749650026702e79.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a139bc749650026702e7d/605a131fc749650026702e79.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a139bc749650026702e7c/605a131fc749650026702e79.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a139bc749650026702e7c/605a131fc749650026702e79.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a139bc749650026702e7b/605a131fc749650026702e79.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a139bc749650026702e7b/605a131fc749650026702e79.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a139bc749650026702e7a/605a131fc749650026702e79.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a139bc749650026702e7a/605a131fc749650026702e79.png"}]
이 아이콘 사용하기 – 무료
가입 시 신용카드가 필요하지 않습니다.

이 아이콘은 BioRender에서 자유롭게 편집할 수 있습니다

  • 텍스트, 도형 및 기타 아이콘 추가
  • 5만 개 이상의 과학적으로 정확한 아이콘을 검색하세요
  • 모든 아이콘, 선, 라벨의 색상과 배치를 자유롭게 변경하세요
  • 어떤 용도로든 내보내거나 공유하세요
Scientist Avatars

이미 출판용 수준의 그림을 만들고 있는 400만 명 이상의 과학자들과 함께하세요

아이콘으로 몇 분 만에 완성된 그림을 만들어 보세요

  • 검색 50,000개 이상의 과학적으로 정확하고 동료 검토를 거친 아이콘 제공
  • 맞춤 설정 라벨, 도형, 추가 아이콘을 사용하여 모든 요소를 자유롭게 편집할 수 있습니다.
  • 내보내기 또는 공동 작업자와 그림 공유하기
    ‍

찾으시는 아이콘이 아닌가요? 더 많은 아이콘을 확인해 보세요.

30개 이상의 생명과학 분야에 걸친 50,000개 이상의 아이콘을 검색하세요.

search icon
arrow-right
lymphoblast,leukemic blast,blast,naive lymphocyte,naive,lymphocyte,agnostic leukemia blast cells,myeloblastic leukemia,leukemia,leukaemia,immature,activated,stimulated,big nucleus,large nucleus,acute lymphoblastic leukemia,ALL,peripheral blood,bone marrow,lymphoblast
더 보기

동의어를 검색하거나 가입하여 앱에서 아이콘을 요청해 보세요.

이미지 유형

Lymphoblast 2 icon JPEG

Lymphoblast 2 icon PNG

Lymphoblast 2 icon SVG

Lymphoblast 2 icon GIF

BioRender 아이콘 FAQ

How are scientists using the Lymphoblast 2 icon in their work?

BioRender users often use the Lymphoblast 2 icon in posters, grant applications, educational materials, and graphical abstracts. It’s especially useful for projects involving Cell Types.

이 아이콘을 BioRender 그림이나 과학 일러스트레이션에 사용할 수 있나요?

Yes, the Lymphoblast 2 is fully integrated into BioRender’s drag-and-drop platform. You can easily add it to any scientific figure, workflow, or poster, whether you’re building from scratch or starting with a BioRender template.

Is the Lymphoblast 2 icon customizable in BioRender?

Most icons in BioRender, including the Lymphoblast 2 icon, are customizable. You can adjust icon size, colors, and positioning, and add custom labels to tailor the design to your specific research context.

Can I export figures that include the Lymphoblast 2 icon for publication or presentations?

Yes, figures containing the Lymphoblast 2 icon can be exported in multiple formats, including PNG, JPG, PDF, and SVG. High-resolution and vector exports are available on paid plans, making them ideal for journals, slide decks, and print materials.

How do I cite BioRender if I use this icon?

Unlock publication permissions with a paid plan, and include 'Created with BioRender.com' in your figure legend, or cite BioRender directly per your journal's guidelines.

Is the Lymphoblast 2 icon used in BioRender templates or poster layouts?

Many BioRender templates include icons like the Lymphoblast 2 icon — especially those focused on Cell Types. You can search BioRender’s template library or add this icon manually to any canvas.

BioRender란 무엇인가요?

BioRender is a web‑based software that helps you create scientific figures in minutes. Use this Lymphoblast 2 icon along with our library of more than 30,000 life science icons.

BioRender에서 이 아이콘 사용하기

지금 바로 전문가 수준의 과학 피규어를 만들어 보세요
antibody elements3D Phospholipid illustration

과학 콘텐츠를 찾고 계신가요?

동료 검토를 거쳐 사용하기 쉽고 무료로 제공되는 5만 개 이상의 아이콘과 템플릿을 살펴보세요.

지금 바로 찾아보세요
x icon